Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$5.45B
-25.9% from 2023
Prescriptions
4.3M
$1,266.91 per claim
Patients
788K
216,578 prescribers
Total spending, 2024
$5.45B
$6,915.21 per patient
Medicare prescription drug plans paid $5.45B for Trulicity in 2024, for 4,303,409 prescriptions and refills to 788,414 patients (down 25.9% from 2023). The average cost per claim was $1,266.91.
California had the highest Medicare cost for Trulicity in 2024: $402.6M for 323,595 claims, followed by New York ($397.6M).
Carlos R Figueroa Nunez, endocrinology in San Juan, PR, had the highest Medicare cost for Trulicity in 2024: 3,098 claims costing $3.2M.
Trulicity is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Carlos R Figueroa Nunez San Juan, PR | Endocrinology | 3,098 | 394 | $3.2M |
| Stella Ilyayeva Rego Park, NY | Internal Medicine | 1,736 | 340 | $2.0M |
| Eugenio Angueira-Serrano |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 199,514 | 4,609,369 | 839,891 | $6.22B |
| 2023 | 219,878 | 5,313,751 | 938,286 | $7.36B |
| 2024 | 216,578 | 4,303,409 | 788,414 | $5.45B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 1,812 |
| 365 |
| $1.9M |
| Carlos A Pla Fernandez Tampa, FL | Endocrinology | 1,578 | 207 | $1.6M |
| Jane Mayrin Philadelphia, PA | Endocrinology | 1,481 | 173 | $1.5M |
| Iraklii Buziashvili Brooklyn, NY | Endocrinology | 1,227 | 257 | $1.3M |
| Jamal Hammoud Flint, MI | Endocrinology | 886 | 231 | $1.3M |
| Jose M Garcia Mateo Ponce, PR | Endocrinology | 1,160 | 153 | $1.2M |
| Farhad Farjoudi San Diego, CA | Endocrinology | 736 | 172 | $1.2M |
| Robert J Pearlstein Plymouth Meeting, PA | Internal Medicine | 1,561 | 186 | $1.1M |
| Jean C Pujals Kury Bayamon, PR | Internal Medicine | 1,102 | 152 | $1.1M |
| Nduche C Onyeaso Fayetteville, NC | Endocrinology | 745 | 173 | $1.1M |
| Phong H Bui Fountain Valley, CA | Internal Medicine | 808 | 131 | $1.1M |
| Joymon K Sebastian Dartmouth, MA | Nurse Practitioner | 889 | 161 | $1.1M |
| Natasha Rodriguez Chicopee, MA | Physician Assistant | 1,003 | 182 | $1.1M |
| Miguel A Ariza Dracut, MA | Internal Medicine | 804 | 148 | $1.1M |
| Hemant T Thawani Grand Blanc, MI | Endocrinology | 547 | 130 | $988K |
| Mushtaq A Syed Indiana, PA | Internal Medicine | 876 | 185 | $972K |
| Ayman Elkadry Huntington, WV | Endocrinology | 904 | 188 | $965K |
| Monica G Robles Anniston, AL | Endocrinology | 652 | 158 | $953K |
| Anant Jeet Lorain, OH | Endocrinology | 754 | 144 | $952K |
| Joselito C Cabaccan San Jose, CA | Endocrinology | 654 | 148 | $949K |
| Jessica I Rosa Carolina, PR | Endocrinology | 781 | 116 | $907K |
| Natallia Kleshchanka Staten Island, NY | Nurse Practitioner | 843 | 191 | $903K |
| Ashutosh S Pareek Salem, MA | Endocrinology | 511 | 125 | $889K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 4,305,141 | $5.45B |